-
揭開不為人知的掙扎：調查顯示亞洲出生率創新低，不孕症知識落差和情緒衝擊令人擔憂
in PRESS RELEASE 2023 on輝凌藥品 (Ferring Pharmaceuticals) 發佈了題為《Real Voices, New Insights: Eureka Moments for Fertility in Asia》（真實的聲音，嶄新的見解：亞洲生育之旅的關鍵發現）的白皮書。該白皮書包含一項名為「EUREKA」的多國研究調查結果，涵蓋亞洲七個國家，有超過1,465位正在考慮、正在接受或已經完成生育治療的受訪者參與了調查。
-
Ferring Named in Fortune’s 2023 Change the World List
in PRESS RELEASE 2023 onFerring Pharmaceuticals has been named in Fortune’s 2023 Change the World list which recognises companies that have had a positive social impact through activities that are part of their core business strategy.
-
Royalty Pharma and Ferring Pharmaceuticals enter into US $500 million royalty agreement for new intravesical gene therapy Adstiladrin® (nadofaragene firadenovec-vncg)
in PRESS RELEASE 2023 onRoyalty Pharma to pay Ferring $300 million upfront and a potential…
-
Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors
in PRESS RELEASE 2023 onJean-Frédéric Paulsen appointed Executive Chairman as Ferring enters new phase of growth Lars Rebien Sørensen appointed Vice-Chairman of Board of Directors supporting transition to new Executive Chairman…
PRESS RELEASE 2023
PRESS RELEASE 2023